Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul 31:2018:5750298.
doi: 10.1155/2018/5750298. eCollection 2018.

The Place of In Vitro Maturation in PCO/PCOS

Shital Julania  1 , Melanie L Walls  2   3 , Roger Hart  3   4
Affiliations
Review

The Place of In Vitro Maturation in PCO/PCOS

Shital Julania et al. Int J Endocrinol. .

Abstract

In vitro maturation (IVM) of human oocytes is an emerging treatment option for women with polycystic ovary/polycystic ovary syndrome (PCO/PCOS) in addition to the standard in vitro fertilization (IVF) treatment. There has been significant improvements in pregnancy rates with IVM over the last two decades. This article reviews the place of IVM for women with PCO/PCOS, placing an emphasis on the predictors of successful pregnancy, optimization of culture media, IVM protocols, pregnancy rates, and neonatal outcomes following IVM treatment.

PubMed Disclaimer

References

    1. Costello M. F., Misso M. L., Wong J., et al. The treatment of infertility in polycystic ovary syndrome: a brief update. The Australian & New Zealand Journal of Obstetrics & Gynaecology. 2012;52(4):400–403. doi: 10.1111/j.1479-828X.2012.01448.x. - DOI - PubMed
    1. Hart R., Hickey M., Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology. 2004;18(5):671–683. doi: 10.1016/j.bpobgyn.2004.05.001. - DOI - PubMed
    1. Tannus S., Hatirnaz S., Tan J., et al. Predictive factors for live birth after in vitro maturation of oocytes in women with polycystic ovary syndrome. Archives of gynecology and obstetrics. 2018;297(1):199–204. doi: 10.1007/s00404-017-4561-z. - DOI - PubMed
    1. Walls M. L., Hunter T., Ryan J. P., Keelan J. A., Nathan E., Hart R. J. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes. Human Reproduction. 2015;30(1):88–96. doi: 10.1093/humrep/deu248. - DOI - PubMed
    1. Tang H., Mourad S., Zhai S.-D., Hart R. J. Dopamine agonists for preventing ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews. 2016;(11, article CD008605) doi: 10.1002/14651858.CD008605.pub3. - DOI - PMC - PubMed

LinkOut - more resources